文献速递心血管US

三尖瓣反流进展的决定因素及其对充分管理的意义

Determinants of Tricuspid Regurgitation Progression and Its Implications for Adequate Management.
PubMed 文献 · JACC Cardiovasc Imaging · 2023-12-06

前瞻性随访1843例至少中度三尖瓣反流患者,中位2.3年随访中19%出现进展;基线中度三尖瓣反流患者1年、2年、3年进展率分别为4.9%、10.1%、24.8%。年龄较大、体重指数较低、慢性肾病、NYHA功能分级较差和右心室扩张与三尖瓣反流进展独立相关;进展与心血管死亡和心力衰竭住院增加相关(P<0.001)。

要点

  • 至少中度三尖瓣反流患者中位2.3年随访19%出现进展,基线中度者3年进展率达24.8%。
  • 年龄较大、体重指数较低、慢性肾病、NYHA功能分级较差、右心室扩张与三尖瓣反流进展独立相关。
  • 三尖瓣反流进展与心血管死亡和心力衰竭住院增加相关(P<0.001),无论初始反流严重程度如何。

核心结论

  • 三尖瓣反流进展存在明显的个体差异,妨碍了准确的随访;无论初始三尖瓣反流严重程度如何,三尖瓣反流进展均是生存的决定因素。

研究设计与样本

  • 前瞻性研究,共纳入1843例至少中度三尖瓣反流患者,连续进行超声心动图研究和/或临床评估随访,随访不足2年者被排除;记录临床和超声心动图特征、心力衰竭住院、心血管死亡和干预措施以评估其对三尖瓣反流进展的影响。

关键影像表现/征象

  • 中位2.3年随访期间19%的患者出现三尖瓣反流进展。
  • 基线中度三尖瓣反流患者1年、2年、3年进展率分别为4.9%、10.1%、24.8%。
  • 三尖瓣反流进展与心腔扩张增加、心室-动脉耦联降低及左心室射血分数降低相关(P<0.001)。

诊断标准与关键数值

  • 三尖瓣反流进展的独立相关因素:年龄较大(HR:1.03)、体重指数较低(HR:0.95)、慢性肾病(HR:1.55)、NYHA功能分级较差(HR:1.52)、右心室扩张(HR:1.33)。

临床应用与阅片要点

  • 三尖瓣反流进展与心血管死亡和心力衰竭住院增加相关(P<0.001)。
  • 三尖瓣反流进展存在明显个体差异,可能妨碍准确的随访。

局限性

  • 三尖瓣反流的自然病史证据缺乏,尤其是进展的变化模式和临床影响方面。
  • 随访不足2年的患者被排除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Tricuspid regurgitation (TR) is associated with an increased mortality. Previous studies have analyzed predictors of TR progression and the clinical impact of baseline TR. However, there is a lack of evidence regarding the natural history of TR: the pattern of change and clinical impact of progression.

OBJECTIVES: The authors sought to evaluate predictors of TR progression and assess the prognostic impact of TR progression.

METHODS: A total of 1,843 patients with at least moderate TR were prospectively followed up with consecutive echocardiographic studies and/or clinical evaluation. All patients with less than a 2-year follow-up were excluded. Clinical and echocardiographic features, hospitalizations for heart failure, and cardiovascular death and interventions were recorded to assess their impact in TR progression.

RESULTS: At a median 2.3-year follow-up, 19% of patients experienced progression. Patients with baseline moderate TR presented a rate progression of 4.9%, 10.1%, and 24.8% 1 year, 2 years, and 3 years, respectively. Older age (HR: 1.03), lower body mass index (HR: 0.95), chronic kidney disease (HR: 1.55), worse NYHA functional class (HR: 1.52), and right ventricle dilation (HR: 1.33) were independently associated with TR progression. TR progression was associated with an increase in chamber dilation as well as a decrease in ventriculoarterial coupling and in left ventricle ejection fraction (P < 0.001). TR progression was associated with an increased cardiovascular mortality and hospitalizations for heart failure (P < 0.001).

CONCLUSIONS: Marked individual variability in TR progression hindered accurate follow-up. In addition, TR progression was a determinant for survival regardless of initial TR severity.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Arteagoitia Bolumburu A, Monteagudo Ruiz JM, Mahia P, et al. Determinants of Tricuspid Regurgitation Progression and Its Implications for Adequate Management. JACC Cardiovasc Imaging. 2023. PMID: 38069980. doi:10.1016/j.jcmg.2023.10.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。